65,437 trials
Obesity
Primary: Response to Food Related Cues Using Functional Magnetic Resonance Imaging - Superior Frontal — -0.35; 0.34 percent activation
Chronic Myelogenous Leukemia · Acute Myelogenous Leukemia · Chronic Lymphocytic Leukemia
Primary: Survival and Non-relapse Mortality at Day +200 Using the Miltenyi Reagent System — 43; 4 participants
Chronic Hepatitis C Infection
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment; Noninferiority Analyses of Each Treatment Arm Compared to Historical Rate — 99.5…
Primary Open Angle Glaucoma
Primary: Mean Intra Ocular Pressure (IOP) at 8.00am — 16.6; 16.3; 17; 15.7 mmHg
Wheelchair Users
Primary: Number of Participants Reported the Endeavor to be the Same as Their Current w/c or Better With Regards to Transporting in a Vehicle — 10 participants
Idiopathic Pulmonary Fibrosis
Primary: Drug-related Adverse Events — 1; 0; 0; 7 participants
Chronic Hepatitis C Infection · Compensated Cirrhosis
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment — 91.8; 96.5 Percentage of participants
CML (Chronic Myelogenous Leukemia) · CLL (Chronic Lymphocytic Leukemia) · AML (Acute Myelogenous Leukemia)
Primary: To Determine if Selective T Cell Depletion Using the Photodepletion Procedure Can Substantially Reduce the Rate of Severe Acute GVHD (Grade III/IV) After Matched Sibling…
Chronic Hepatitis C Infection
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment — 96.4 percentage of participants
Diabetes
Primary: Percent of Self Test Fingerstick Blood Glucose Results Within ±15 mg/dL (< 75 mg/dL) and Within ±20% (≥ 75 mg/dL) of the Laboratory Glucose Method — 99.09 percentage of…
Adenomatous Polyp · Recurrent Colon Cancer · Recurrent Rectal Cancer
Primary: Change in ACF pERK Levels
Chronic Hepatitis C Infection
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment; Primary Analyses — 97.7; 100 percentage of participants
Adult Giant Cell Glioblastoma · Adult Glioblastoma · Adult Gliosarcoma
Primary: Number of Patients Achieving 6-month Progression-free Survival (6mPFS) — 1; 2 participants
Pulmonary Fibrosis
Primary: Rate of Decline in FVC — -0.190; -0.174; -0.210; -0.162 Liters/year — p=0.8530
Cutaneous Leiomyomas · Hereditary Leiomyomatosis and Renal Cell Cancer
Primary: Change in Worst Lesional Pain in the Past Week Based on Brief Pain Inventory — -2.50; -1.26 units on a scale